Exact Sciences
EXAS
#1104
Rank
C$28.71 B
Marketcap
C$150.43
Share price
0.00%
Change (1 day)
98.39%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.63. In 2024 the company made an earnings per share (EPS) of C-$7.99.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.63-4.45%
2024C-$7.99
2022C-$5.082.31%
2021C-$4.96-38.54%
2020C-$8.07692.96%
2019C-$1.02-50.69%
2018C-$2.0644%
2017C-$1.43-39.39%
2016C-$2.37-2.94%
2015C-$2.4437.1%
2014C-$1.7879.71%
2013C-$0.99-21.59%
2012C-$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.84-137.23%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$2.28-129.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.49-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$1.95-74.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$72.99 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA